# EDGAR Filing Document

**Accession Number:** 0000059478
**File Stem:** 0000059478-25-000161
**Filing Date:** 2025-6
**Character Count:** 5547
**Document Hash:** 30faba24362312a0da1e7f4b767412af
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000059478-25-000161.hdr.sgml**: 20250606

**ACCESSION NUMBER**: 0000059478-25-000161

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 5

**CONFORMED PERIOD OF REPORT**: 20250601

**FILED AS OF DATE**: 20250606

**DATE AS OF CHANGE**: 20250606

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Custer Kenneth L.
- **CENTRAL INDEX KEY:** 0002071542

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-06351
- **FILM NUMBER:** 251030766

**MAIL ADDRESS:**
- **STREET 1:** C/O ELI LILLY AND COMPANY
- **STREET 2:** 893 S DELAWARE STREET
- **CITY:** INDIANAPOLIS
- **STATE:** IN
- **ZIP:** 46225
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ELI LILLY & Co
- **CENTRAL INDEX KEY:** 0000059478
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 350470950
- **STATE OF INCORPORATION:** IN
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** LILLY CORPORATE CTR
- **STREET 2:** DROP CODE 1094
- **CITY:** INDIANAPOLIS
- **STATE:** IN
- **ZIP:** 46285
- **BUSINESS PHONE:** 3172762000

**MAIL ADDRESS:**
- **STREET 1:** LILLY CORPORATE CENTER
- **STREET 2:** DROP CODE 1094
- **CITY:** INDIANAPOLIS
- **STATE:** IN
- **ZIP:** 46285

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LILLY ELI & CO
- **DATE OF NAME CHANGE:** 19941024

## Ex-24

![](kennethcuster-secpoasign001.jpg)

------

![](kennethcuster-secpoasign002.jpg)

------

![](kennethcuster-secpoasign003.jpg)

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Custer Kenneth L.<br><sub>(Last) (First) (Middle)</sub><br>LILLY CORPORATE CENTER<br><sub>(Street)</sub><br>INDIANAPOLIS, IN 46285<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>ELI LILLY & Co [ LLY ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-06-01 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_EVP & President, Card Met Hlth_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 9328.82 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Restricted Stock Unit | 2026-11-01 | 2026-11-01 | Common Stock | 3220 | <sup>(1)</sup> | D |  |
| Restricted Stock Unit | 2026-02-16 | 2026-02-16 | Common Stock | 207 | <sup>(1)</sup> | D |  |
| Restricted Stock Unit | 2027-02-16 | 2027-02-16 | Common Stock | 209 | <sup>(1)</sup> | D |  |
| Restricted Stock Unit | 2028-02-16 | 2028-02-16 | Common Stock | 177.045 | <sup>(1)</sup> | D |  |
| Phantom Stock | <sup>(2)</sup> | <sup>(2)</sup> | Common Stock | 1557.32 | <sup>(3)</sup> | D |  |

---

### Footnotes:

(1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

(2) Shares of phantom stock are payable in cash following termination of the reporting person's employment with Eli Lilly and Company. The reporting person may transfer his phantom stock account into an alternative investment account at any time.

(3) Each share of phantom stock represents the right to receive the cash value of one share of Eli Lilly and Company common stock.

**Remarks:**
Exhibit 24 - Power of Attorney

**Signature:** /s/ Jonathan Groff for Kenneth Custer, pursuant to authorization attached  
**Date:** 2025-06-06

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**